For research use only. Not for therapeutic Use.
L-Octanoylcarnitine is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine can be used for the research of breast cancer[1][2][3].
L-Octanoylcarnitine (0.2 mM) induces H2O2 release of rat liver mitochondria (RLM)[2].
L-Octanoylcarnitine decreases mucosal and detrusor force-flow respiration and respiratory conductance in male high fat diet (HFD) mice[3].
Catalog Number | I019798 |
CAS Number | 25243-95-2 |
Synonyms | (3R)-3-octanoyloxy-4-(trimethylazaniumyl)butanoate |
Molecular Formula | C15H29NO4 |
Purity | ≥95% |
InChI | InChI=1S/C15H29NO4/c1-5-6-7-8-9-10-15(19)20-13(11-14(17)18)12-16(2,3)4/h13H,5-12H2,1-4H3/t13-/m1/s1 |
InChIKey | CXTATJFJDMJMIY-CYBMUJFWSA-N |
SMILES | CCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C |
Reference | [1]. Kim M, et al. Association between arterial stiffness and serum L-octanoylcarnitine and lactosylceramide in overweight middle-aged subjects: 3-year follow-up study. PLoS One. 2015 Mar 17;10(3):e0119519. [2]. Schönfeld P, Reiser G. Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration. J Cereb Blood Flow Metab. 2017 Mar;37(3):848-854. [3]. Hanna Kosnik, et al. CHRONIC HIGH FAT DIET IMPAIRS DETRUSOR MITOCHONDRIAL FATTY ACID OXIDATION IN MALE BUT NOT FEMALE MICE. Journal of UrologyBladder & Urethra: Anatomy, Physiology & Pharmacology I (MP11)1 Apr 2019. |